Jean-Philippe Lafrance publishes Pharmacoepidemiology and Drug Safety: Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
Mélanie Béland publishes in Molecular cancer research: Calcineurin a-binding protein, a novel modulator of the calcineurin nuclear factor of activated T-cell signaling pathway, is overexpressed in wilms' tumors and promotes cell migration.
Darren Yuen publishes in Hypertension: The (Pro)Renin Receptor. Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney.
Michael Walsh publishes in Kidney International: Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis.
The KRESCENT Program is a Strategic Training Program developed and supported by:
With additional generous support from:
AMGEN Baxter Corporation Merck-Frosst Canada Ltd. Ortho Biotech RocheShire BioChem Inc.
